Background It is unclear whether transplanted stem cells, despite their functional benefits, survive and engraft in the heart following transplantation. hAMSCs exhibit cell surface markers of immunomodulation (HLA-DR -, HLA-G +, CD59 +) that may enhance survival after transplantation. To investigate the viability of hAMSCs in vivo, we used a MEMRI contrast agent, EVP-1001-1 (Eagle Vision Pharmaceuticals, Inc) in a porcine ischemia-reperfusion (IR) injury model. EVP-1001-1 specifically enters live cells via L-type Ca2+ channels. Following EVP-1001-1 injection, MEMRI delineates the infarct zones through T1 signal loss. EVP-1001-1 also produces increased T1 signal in isolated hAMSCs.
Methods
Seven adult farm pigs underwent 60 min LAD coronary IR. One week post-IR, pigs hearts were injected with either hAMSCs (~80 million cells/heart, n=4) or normal saline (NS, n=3) into~8 peri-infarct and infarct zones, by intraventricular catheter injection (Biocardia, Inc.). Cardiac MRI (CMR) was performed serially to assess ejection fraction (EF%), infarct % by delayed gadolinium Enhancement MRI (DEMRI), and myocardial viability % (MEMRI). 
Results
hAMSC and NS EFs were similar at baseline (57±4%, n=5) and 1wk post-IR (24±6%). However, hAMSC injection improved EFs at 1, 2, & 3wks post-hAMSC delivery, compared to NS-injected swine ( Fig 1A) . A possible mechanism for the improvement was increased peri-infarct viability. In support of this, MEMRI defect (infarct) volume decreased from d7 to d21 post-IR in hAMSC hearts (60±12% reduction, n=3) more than in NS hearts (38±18% reduction ; Fig 1 F,G) . MEMRI also identified foci of high contrast-to-noise ratio (CNR) within infarct zones in hAMSC hearts (hAMSC: 8.6±1.4*; NS: 4.9±0.8, n=3, *p<0.05 Fig 1D,1E ), suggesting increased EVP-1001-1 uptake by live hAMSCs within the infarct zone. This signal also increased from d10 to d17. In two swine, 20% of the hAMSCs were transduced with a HSV-tk PET reporter gene, and cardiac PET imaging confirmed co-localizing PET and MEMRI signals (Fig 1H) , indicating live stem cell populations ( Fig 1I) . Human anti-mitochondrial Ab immunostaining revealed viable hAMSC cell clusters in infarct zones 38 days post-transplantation. 
